FDA asks Novavax to complete new clinical trial for delayed COVID-19 shot, WSJ reportsReuters • 04/25/25
Novavax (NVAX) Surges 19.5%: Is This an Indication of Further Gains?Zacks Investment Research • 04/24/25
SHIELD-Utah Study Shows Novavax's COVID-19 Vaccine Induces Lower Reactogenicity Symptoms Compared to mRNAPRNewsWire • 04/15/25
NVAX Stock Tanks as HHS Secretary Raises Concern Over COVID-19 JabZacks Investment Research • 04/11/25
Novavax shares tumble after U.S. health secretary raises concerns over COVID shot's efficacyReuters • 04/10/25
The FDA was moving to grant full approval for Novavax's Covid-19 vaccine. But it missed the April 1 deadline after the agency's vaccine chief was forced out.WSJ • 04/02/25
Biotech Stocks Fall After Top FDA Official Quits Over Clash With RFK Jr.Zacks Investment Research • 04/01/25
Vaccine stocks tumble: Moderna, Novavax, Pfizer fall after top FDA official resigns over RFK Jr. anti-vax viewsFast Company • 03/31/25
Moderna, Vaxcyte, Novavax Hammered After Key FDA Official Peter Marks ResignsInvestors Business Daily • 03/31/25
Novavax, Inc. (NVAX) Leerink Partners 2025 Global Healthcare Conference (Transcript)Seeking Alpha • 03/11/25